Cryoport, Inc. — Director's Dealing 2025

Mar 19, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cryoport, Inc. (CYRX)
CIK: 0001124524
Period of Report: 2025-03-14

Reporting Person: STEFANOVICH ROBERT (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-03-14	Common Stock	A	10000	—	Acquired	193078	Direct
2025-03-17	Common Stock	S	1659	$6.2917	Disposed	191419	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-03-14	Stock Option (right to buy)	$7.05	A	25000	Acquired	2032-03-14	Common Stock (25000)	Direct

Footnotes

F1: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2026.

F2: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.

F3: 1/48 of options vest on the 14th of each month for forty-eight months beginning April 14, 2025.